Delivery Order SPE2DB20D2014-SPE2DB25FC76V
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $2,761.61 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed and delivered from the vendor's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% patches (30-count units) with a ceiling value of $11,357.36. This firm fixed-price delivery order, which is expected to be completed by August 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for Lidocaine 5% Patch in a quantity of 30 units, valued at $9,852.90. This competitively awarded, non-set-aside delivery order represents a firm fixed-price pharmaceutical supply transaction supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $5,556.22. This is a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is not subject to any small business set-aside designation and represents a competitively awarded...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,363.52 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued...
- The Defense Logistics Agency awarded a $10,616.14 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Lidocaine 5% patches (30-count units). This is a firm fixed-price, non-set-aside contract with performance to be completed by August 1, 2025, and fulfillment occurring at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,022.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% patches on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,438.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued to the pharmaceutical distributor's Corporate Office in Conshohocken, Pennsylvania. The delivery order represents a routine medical procurement fulfilling the federal government's pharmaceutical supply needs for military and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC76VDelivery Order
The Defense Logistics Agency awarded a $2,205.36 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% patches (30-count). This competitively awarded, firm fixed price contract is scheduled for completion by August 18, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive range of medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/15/25 |